This Biotech Fund Made a New $40 Million Bet on Liquidia Amid Blockbuster Commercial Drug Launch

California-based TCG Crossover Management disclosed a new position in Liquidia Corporation (NASDAQ:LQDA) valued at approximately $38.9 million in an SEC filing on Friday.According to a filing with the Securities and Exchange Commission released on Friday, TCG Crossover Management initiated a new position in Liquidia Corporation (NASDAQ:LQDA), acquiring 1.7 million shares for an estimated $38.9 million during the third quarter. This new stake accounts for 1.9% of the fund’s reportable U.S. equity assets as of September 30, bringing the total number of reportable positions to 40.Top holdings after the filing:  Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool